A 3D Framework for Strategic Co-Creation in Pharma

 

Co-creation is no longer a nice-to-have. It’s an essential capability for delivering meaningful, measurable value to patients, healthcare professionals, and systems. Yet in practice, co-creation often remains fragmented — reduced to isolated pilots or symbolic workshops.

This whitepaper introduces a 3D model that helps pharma leaders, cross-functional teams, and policy stakeholders evaluate and scale co-creation strategically.

 

What you’ll learn:

• A clear definition of co-creation in the pharmaceutical context

• A structured 3D model across three key dimensions:
  → Customer Experience
  → Organizational Maturity
  → Level of Application

• Real-world pharma examples mapped in the model

• Strategic prompts, risk zones, and governance implications

• Tools to support assessment, prioritization, and transformation

 

Who should read this:

• Market access & medical affairs professionals

• CX, PSP, and innovation teams

• Policy and compliance stakeholders

• Anyone working to make co-creation real — and scalable — in pharma

 

Get the whitepaper

Fill in the form to download your copy and take the next step toward embedding co-creation in strategy, structure, and everyday decisions.